Category Archives: TB

Concurrent treatment for HIV/TB co-infection breaks up “deadly alliance”

By on .

In a continuation of World TB Day coverage, the following guest post from study authors Martha Priedeman Skiles and Stephanie Mullen tells how current data from Ukraine show promise for patients co-infected with TB and HIV.  By Martha P. Skiles and Stephanie Mullen, MEASURE Evaluation Although tuberculosis is a curable disease, it has devastating consequences on public […]

TB survivors from Indonesia, Tajikistan, South Africa tell stories of unique challenges, common ordeals, and continued toll

By on .

A South African nurse described the shame and denial that complicated her treatment for tuberculosis. An Indonesian mother of three recounted the months of debilitating treatment and isolation during which she considered suicide. A man from Tajikistan told how he completed treatment for multidrug-resistant TB the month he lost his second brother to the disease. […]

From calls to action to ambitious new plans, the global health community commemorates World TB Day

By on .

Increasing Access to Child-Friendly TB Treatment: The TB Alliance announced today a partnership with the U.S. Fund for UNICEF to include the diagnosis and treatment of pediatric TB in UNICEF child and maternal health programs around the world. It’s estimated that every year over half a million children suffer from TB and as many as […]

MSF: More than a quarter of MDR-TB cases in Swaziland not caught by “front line of defense” in fighting the disease

By on .

The nonprofit medical humanitarian organization Médecins Sans Frontières is recommending that all patients in Swaziland who have tested positive for TB, but rapid molecular testing has found negative for drug-resistance undergo further testing, following findings that a mutation has made more than a quarter of multidrug-resistant strains undetectable by the widely used test. MSF, its […]

TB advocates call on organizations, leaders to work together, speed access to existing treatments for drug resistant tuberculosis

By on .

They would like an answer on March 24 When World TB Day next Tuesday commemorates the discovery in 1882 of the bacteria that causes the disease, announcements and op-ed pieces will note the progress that has been made since, and will certainly call for more. A group of 89 organizations that last week sent a […]

Large scale TB screening in prisons, jails can be done, should be done, researchers say

By on .

A program that screened more than 7000 inmates for tuberculosis at four South Africa correctional facilities showed that a large number of inmates could be diagnosed with TB and quickly begin treatment in a setting where confronting the disease is widely considered critical to broader public health objectives, an article released today in Open Forum […]

With $30 million worth of bedaquiline, drug maker donates 30,000 courses of TB treatment

By on .

Global TB response advocates express continued concern about drug’s price First, a word about the significance of bedaquiline. The first new antituberculosis drug to be developed in nearly half a century, it was given fast-tracked approval by the U.S. Food and Drug Administration at the end of 2012 to speed access to the drug for […]

Beating TB requires more than medicine: The value of patient support

By on .

The following is a guest post by Emily Delmotte of Management Sciences for Health Eight years ago Busisiwe Beko was undergoing treatment for multidrug-resistant tuberculosis when, after months of waiting to see a pediatric specialist, her daughter was diagnosed with the same illness. The five-month-old baby was admitted to a TB hospital where she would […]

45th Union World Conference on Lung Health: Alarm Bells about TB and Diabetes

By on .

BARCELONA, Spain –  The opening press conference of the 45th Union World Conference on Lung Health highlighted a new report calling for international action against the latest co-epidemic, tuberculosis and diabetes. With alarming similarities to the deadly synergy of HIV/TB, the intersection between tuberculosis and diabetes compromises treatment outcomes for both diseases, Dr. Anthony Harries told a packed […]

IDWeek: Some progress in TB drug and diagnostic development, but not enough

By on .

The emerging crisis of multidrug-resistant tuberculosis is a “personal and health system catastrophe” that’s occurring half a million times a year in the form of new cases, Eric Nuermberger said at an IDWeek session on HIV-related opportunistic diseases. Not only is it an intensively difficult disease to treat, requiring up to two years of therapy […]